ID

14928

Descripción

This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: Check for Study Continuation

Palabras clave

Versiones (1)
  1. 8/5/16 8/5/16 -
Subido en

8 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Check for Study Continuation Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396

Inglés

Check for Study Continuation "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 formularios  
Identification
Descripción

Identification

Alias
UMLS CUI-1
C1300638
Center number
Descripción

Center number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0805701
Subject ID
Descripción

Subject ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Treatment Number
Descripción

Treatment Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1522541
Visit Number
Descripción

Visit Number

Tipo de datos

integer

Alias
UMLS CUI [1]
C0545082
Check for Study Continuation
Descripción

Check for Study Continuation

Did the subject return for visit 2
Descripción

Yes, Please complete the next pages No, Please tick the ONE most appropriate reason and skip the following pages of this visit.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2827364
most appropriate reason
Descripción

If Serious adverse event - Please complete and submit SAE report - Please specify SAE No. If Non-Serious adverse event - Please complete Non-serious Adverse Event section - Please specify AE No. or solicited AE code If Other, please specify (e.g.: consent withdrawal, Protocol violation, ... )

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0392360
Code of SAE,AE or solicited AE
Descripción

Code of SAE,AE,solicited AE or specification

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Who made the decision
Descripción

Who made the decision

Tipo de datos

text

Alias
UMLS CUI [1]
C1389424
Laboratory Tests:Blood Sample
Descripción

Laboratory Tests:Blood Sample

Has a Blood Sample been taken
Descripción

Blood Sample

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005834
Date of sample
Descripción

Only fill in if different from visit date

Tipo de datos

date

Alias
UMLS CUI [1]
C0460065
Volver a la parte superior de la página

Similar models

Check for Study Continuation "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Identification
C1300638 (UMLS CUI-1)
Center number
Item
Center number
text
C1301943 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Treatment Number
Item
Treatment Number
text
C1522541 (UMLS CUI [1])
Item
Visit Number
integer
C0545082 (UMLS CUI [1])
Visit Number
Code List
Visit Number
CL Item
1 (1)
CL Item
2 (2)
Item Group
Check for Study Continuation
Did the subject return for visit 2
Item
Did the subject return for visit 2
boolean
C2827364 (UMLS CUI [1])
Item
most appropriate reason
text
C0679823 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
most appropriate reason for Absence
Code List
most appropriate reason
CL Item
Serious adverse event (SAE)
CL Item
Non-Serious adverse event (AEX)
CL Item
Other (OTH)
Code of SAE,AE,solicited AE or specification
Item
Code of SAE,AE or solicited AE
text
C0877248 (UMLS CUI [1])
Item
Who made the decision
text
C1389424 (UMLS CUI [1])
Who made the decision:
Code List
Who made the decision
CL Item
Investigator (I)
CL Item
Parents/Guardians (P)
Blood Sample
Item
Has a Blood Sample been taken
boolean
C0005834 (UMLS CUI [1])
Date of sample
Item
Date of sample
date
C0460065 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial